Ginkgo Bioworks
GenomeWeb Top 40 Drops 3 Percent in 2024, Reflecting Larger Life Science Struggles in Stock Market
The Dow Jones Industrial Average rose 13 percent year over year, and the Nasdaq rose 29 percent, but the Nasdaq Biotech Index declined 1 percent.
GenomeWeb Top 40 Falls 3 Percent in December Amid Mixed Broader Market
The Dow Jones Industrial Average fell 5 percent while the Nasdaq rose by less than 1 percent, and the Nasdaq Biotech Index dropped 7 percent.
Ginkgo Bioworks Posts 21 Percent Drop in Q3 Recurring Revenues
The revenue drop does not include the impact of millions in non-cash deferred revenue tied to a mutually terminated alliance.
Use of genomics-focused generative AI models for cells has exploded over the last year, changing the way scientists interact with data and conduct studies.
GenomeWeb Top 40 Rises 2 Percent in September, Largely Tracking Broader Market
Of the 40 firms tracked by GenomeWeb, 21 saw their stock prices rise month over month and 19 saw their shares decrease in value.
Jun 25, 2024
Ginkgo Bioworks to Lay off 35 Percent of Workforce
May 15, 2024
BTIG Downgrades Ginkgo Bioworks to Sell Rating
Mar 1, 2024